X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2245) 2245
Book Review (988) 988
Publication (79) 79
Book Chapter (5) 5
Conference Proceeding (3) 3
Book / eBook (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1840) 1840
humans (1691) 1691
female (913) 913
low-dose aspirin (883) 883
low-dose heparin (709) 709
molecular-weight heparin (626) 626
male (564) 564
deep-vein thrombosis (492) 492
prevention (430) 430
risk factors (421) 421
hematology (420) 420
pregnancy (415) 415
anticoagulants - therapeutic use (411) 411
middle aged (392) 392
adult (369) 369
aged (365) 365
abridged index medicus (354) 354
peripheral vascular disease (327) 327
aspirin (325) 325
surgery (316) 316
venous thromboembolism (313) 313
heparin (294) 294
heparin - therapeutic use (250) 250
medicine, general & internal (240) 240
thrombosis (240) 240
unfractionated heparin (239) 239
thromboembolism (224) 224
aspirin - therapeutic use (223) 223
treatment outcome (220) 220
anticoagulants (217) 217
prophylaxis (214) 214
heparin, low-molecular-weight - therapeutic use (213) 213
obstetrics & gynecology (207) 207
pulmonary-embolism (198) 198
cardiac & cardiovascular systems (195) 195
double-blind (192) 192
pharmacology & pharmacy (192) 192
venous thrombosis - prevention & control (192) 192
animals (185) 185
platelet aggregation inhibitors - therapeutic use (184) 184
thromboembolism - prevention & control (184) 184
venous thrombosis (183) 183
fibrinolytic agents - therapeutic use (171) 171
anticoagulants - administration & dosage (166) 166
postoperative complications - prevention & control (164) 164
oncology (160) 160
medicine & public health (157) 157
randomized controlled-trial (157) 157
health aspects (154) 154
anticoagulants - adverse effects (150) 150
drug therapy (150) 150
women (147) 147
randomized controlled trials as topic (139) 139
total hip-replacement (135) 135
care and treatment (134) 134
prospective studies (134) 134
therapy (134) 134
aged, 80 and over (132) 132
risk (132) 132
pulmonary embolism (129) 129
randomized trial (129) 129
low-dose warfarin (127) 127
venous thromboembolism - prevention & control (127) 127
risk-factors (125) 125
retrospective studies (124) 124
analysis (123) 123
cancer (119) 119
acute myocardial-infarction (113) 113
antiphospholipid syndrome (113) 113
aspirin - administration & dosage (113) 113
pulmonary embolism - prevention & control (112) 112
heparin - administration & dosage (110) 110
placebo-controlled trial (110) 110
thrombosis - prevention & control (110) 110
antiphospholipid antibodies (109) 109
complications (109) 109
dose-response relationship, drug (109) 109
low-molecular-weight (109) 109
risk assessment (108) 108
thromboprophylaxis (107) 107
time factors (102) 102
fatal pulmonary-embolism (100) 100
incidence (100) 100
clinical trials as topic (99) 99
myocardial-infarction (99) 99
hemorrhage - chemically induced (98) 98
research (96) 96
pregnancy outcome (94) 94
respiratory system (93) 93
trial (93) 93
enoxaparin (92) 92
heparin - adverse effects (92) 92
warfarin (92) 92
mortality (89) 89
preeclampsia (89) 89
intermittent pneumatic compression (88) 88
fetal loss (87) 87
thrombophilia (87) 87
critical care medicine (85) 85
anticoagulation (84) 84
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2107) 2107
French (56) 56
German (51) 51
Spanish (13) 13
Japanese (12) 12
Portuguese (4) 4
Russian (3) 3
Chinese (2) 2
Korean (2) 2
Czech (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Fertility and Sterility, ISSN 0015-0282, 2012, Volume 98, Issue 4, pp. 1028 - 1036.e2
Objective To examine the effects of low molecular weight heparins (LMWHs) on extravillous trophoblast (EVTC) invasiveness and on EVTC expression/secretion of... 
Internal Medicine | Obstetrics and Gynecology | MMP-2 | HB-EGF | tinzaparin | low molecular weight heparins | enoxaparin | AP-1 | Extravillous trophoblast invasiveness | Cyr61 | IMMEDIATE-EARLY GENE | CELL-ADHESION | RANDOMIZED CONTROLLED-TRIAL | OBSTETRICS & GYNECOLOGY | IN-VITRO | REPRODUCTIVE BIOLOGY | LOW-DOSE ASPIRIN | ASPIRIN PLUS HEPARIN | PLACENTAL APOPTOSIS | RECURRENT PREGNANCY LOSS | DECREASED EXPRESSION | UNFRACTIONATED HEPARIN | Abortion, Habitual - pathology | Heparin, Low-Molecular-Weight - pharmacology | Humans | Cysteine-Rich Protein 61 - metabolism | Transcription Factor AP-1 - metabolism | Cell Movement - physiology | Trophoblasts - drug effects | Intercellular Signaling Peptides and Proteins - metabolism | Cysteine-Rich Protein 61 - secretion | Placenta - cytology | Abortion, Habitual - drug therapy | Female | Trophoblasts - cytology | Intercellular Signaling Peptides and Proteins - secretion | Cell Differentiation - physiology | Trophoblasts - metabolism | Matrix Metalloproteinase 2 - metabolism | Cells, Cultured | Enoxaparin - pharmacology | Placenta - drug effects | Pregnancy | Cell Movement - drug effects | Fibrinolytic Agents - pharmacology | Heparin-binding EGF-like Growth Factor | Cell Differentiation - drug effects | Anticoagulants - pharmacology | Thrombosis - drug therapy | Anticoagulants (Medicine) | Glycosaminoglycans | DNA-ligand interactions | Protein binding | Index Medicus
Journal Article
Journal Article
Trials, ISSN 1745-6215, 2015, Volume 16, Issue 1, pp. 208 - 208
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 11/2004, Volume 44, Issue 9, pp. 1792 - 1800
Journal Article
Journal Article
Chest, ISSN 0012-3692, 2016, Volume 150, Issue 3, pp. 506 - 515
Background Almost without exception, patients with heparin-induced thrombocytopenia/thrombosis (HIT) have antibodies that recognize platelet factor 4 (PF4) in... 
Pulmonary/Respiratory | heparin | thrombocytopenia | thrombosis | OPERATING CHARACTERISTIC ANALYSIS | ANTIBODIES | DIAGNOSIS | TESTS | COMPLEX | MANAGEMENT | PLATELET-FACTOR-4 | HIT | RESPIRATORY SYSTEM | COHORT | ELISA | CRITICAL CARE MEDICINE | Thrombosis - chemically induced | Enzyme-Linked Immunosorbent Assay | P-Selectin - metabolism | Humans | Middle Aged | Thrombocytopenia - immunology | Platelet Factor 4 - immunology | Thrombosis - immunology | Male | Thrombocytopenia - chemically induced | Anticoagulants - adverse effects | Heparin - adverse effects | Case-Control Studies | Autoantibodies - immunology | Platelet Activation | Aged, 80 and over | Adult | Female | Thrombocytopenia - diagnosis | Aged | Thrombosis - diagnosis | Activation | Research | Heparin | Blood platelets | Thrombosis | Blood clot | Index Medicus | Abridged Index Medicus | PF4, platelet factor 4 | HDH, high-dose heparin | AUC, area under the curve | GPIIb, glycoprotein IIb | Original Research | OD, optical density | PEA, PF4-dependent P-selectin expression assay | ROC, receiver operating characteristic | SRA, serotonin release assay | HIT, heparin-induced thrombocytopenia | Critical Care | MFI, median fluorescence intensity | PF4 ELISA, IgG-specific heparin (or polyvinyl sulfonate):PF4 enzyme-linked immunosorbent assay | 4Ts, thrombocytopenia, timing of platelet count fall, thrombosis, and other causes of thrombocytopenia | LDH, low-dose herparin
Journal Article